Today: 21 May 2026
SoftBank stock slips in Tokyo as $41bn OpenAI investment and $4bn DigitalBridge deal take center stage
1 January 2026
2 mins read

SoftBank stock slips in Tokyo as $41bn OpenAI investment and $4bn DigitalBridge deal take center stage

NEW YORK, January 1, 2026, 08:19 ET — Market closed

  • SoftBank ended down 1.9% at 4,400 yen in Tokyo’s last session of 2025.
  • The stock cooled as investors weighed SoftBank’s growing bill for AI infrastructure.
  • Tokyo markets are shut for New Year holidays, with trading set to resume next week.

SoftBank Group shares fell on the Tokyo Stock Exchange in the final trading session of 2025 after the company said it had completed a $41 billion investment in OpenAI, deepening CEO Masayoshi Son’s bet on artificial intelligence. The stock closed down 1.9% at 4,400 yen.

The moves matter because SoftBank has been repositioning itself as a major backer of the physical plumbing behind AI — data centers, networks and power capacity needed to run large models — at a time when investors are growing more sensitive to funding needs. That puts a sharper spotlight on how quickly returns arrive versus how quickly cash goes out the door.

Some traders framed the decline as holiday-driven positioning rather than a shift in the AI story. “It appears to be driven by end-of-year adjustment selling amid thin trading,” Nomura Securities strategist Wataru Akiyama said, referring to low liquidity around holidays. The Business Times

Tokyo’s cash equities market is closed for New Year holidays from Jan. 1 through Jan. 3, with no trading on the weekend, according to Japan Exchange Group’s calendar. U.S. stock markets are also closed on Thursday for the New Year holiday.

SoftBank’s latest catalyst is its agreement to acquire U.S. digital infrastructure investor DigitalBridge for about $4 billion, a deal that values the target at $16 a share — a 15% premium — and is expected to close in the second half of 2026, subject to approvals. DigitalBridge is expected to keep operating as a standalone platform.

Broader Tokyo stocks eased into the year-end close, with the Nikkei ending down 0.37% at 50,339.48 and the Topix down 0.51% at 3,408.97, a record year-end level. Jiji Press said heavyweight components such as SoftBank and some nonferrous metal producers weighed on the market amid a quiet holiday period.

SoftBank’s pullback still leaves it in a wide trading range, with Reuters data showing a 52-week band of 1,432.50 yen to 6,923.75 yen. The stock’s last reported session range was 4,332 yen to 4,500 yen.

Overseas, DigitalBridge shares jumped on the deal announcement, reflecting investor expectations for a takeout price anchored by SoftBank’s cash offer and the closing timeline. Barron’s reported the offer price at $16 a share and said the deal is expected to wrap in the second half of 2026.

DigitalBridge manages roughly $108 billion in assets, according to reports tied to the transaction, and its portfolio is concentrated in data-center and connectivity investments. That footprint is central to SoftBank’s pitch that it wants more exposure to the infrastructure layer of AI growth.

Before Tokyo’s next session, SoftBank investors will be looking toward the next company update window: its IR calendar flags third-quarter results in February as a regular milestone. That report is likely to sharpen focus on funding plans, balance-sheet discipline and the pace of AI-related spending.

Deal-watchers are also tracking the paperwork. A DigitalBridge investor-relations filing posted around the announcement outlines the transaction framework and typical merger conditions, keeping attention on regulatory steps and the closing path into 2026.

Stock Market Today

  • Nvidia's Earnings Surge Fuels Massive Buybacks and AI Investments
    May 21, 2026, 5:32 AM EDT. Nvidia's latest earnings showcased an 85% revenue jump to $81.6 billion, driven by a booming AI sector. The chipmaker returned about $20 billion to shareholders through buybacks and raised its quarterly dividend, while authorizing an additional $80 billion in buybacks. It also invested heavily in AI-related firms, holding nearly $74 billion in equity stakes across public and private companies. Data center sales, key to AI growth, soared 92% to $75.2 billion, with free cash flow increasing 86% to $48.6 billion. Nvidia's cash flow now funds both shareholder returns and expanding AI investments, underscoring the scale of its AI-driven business model.

Latest articles

Rocket Lab Shares Slide Premarket On $3 Billion Sale Plan During SpaceX IPO Week

Rocket Lab Shares Slide Premarket On $3 Billion Sale Plan During SpaceX IPO Week

21 May 2026
Rocket Lab filed to sell up to $3 billion in common stock, sending shares down to $126.75 in premarket trading from Wednesday’s $134.28 close. The move comes as SpaceX filed for a public IPO, raising valuation pressure across the sector. Rocket Lab’s year-to-date gain stood near 92% before the late-Wednesday announcement. The company reported $200.3 million in Q1 revenue and a $2.2 billion backlog.
Snowflake Heads Toward $205 BofA Level Before Earnings Next Week

Snowflake Heads Toward $205 BofA Level Before Earnings Next Week

21 May 2026
Snowflake shares fell 1.5% to $166.97 in early Thursday trading after Bank of America raised its price target to $205 and reiterated a Buy rating ahead of fiscal Q1 results due May 27. RBC cut its target earlier this week, highlighting ongoing competition in data and AI. Snowflake previously guided for Q1 product revenue of $1.262–$1.267 billion, up 27% year-over-year.
Arm jumps in premarket on AI chip hopes

Arm jumps in premarket on AI chip hopes

21 May 2026
Arm Holdings shares closed Wednesday at $256.73, up 15.05%, after Bernstein’s David Dai initiated coverage with an outperform rating and a $300 target, citing rising demand for server CPUs driven by agentic AI. The stock touched $259.44 during regular trading. U.S. markets were open; May 21 is not a listed exchange holiday. Arm’s AGI CPU has over $2 billion in expected demand for fiscal 2027 and 2028.
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Previous Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop